$2.12
0.104.95%
At close: -
$2.08
-0.04-1.81%
After Hours: 7:51 PM EDT
Immuneering reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Immuneering using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.49 | $-0.55 | 10.9 % |
Q2 | 2024-08-06 | $-0.47 | $-0.52 | 9.62 % |
Q1 | 2024-05-07 | $-0.49 | $-0.46 | -6.52 % |
Q4 | 2024-03-01 | $-0.52 | $-0.47 | -10.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2023-05-04 | $0 | $10.00K | -100.0 % |
Q4 | 2023-03-06 | $456.00 | $60.00K | -99.2 % |
Q3 | 2022-11-10 | $38.38K | $150.00K | -74.4 % |
Q2 | 2022-08-10 | $94.42K | $180.00K | -47.5 % |
Immuneering (IMRX) is scheduled to report earnings on February 28, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.49, which beat the estimate of $-0.55.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.